Price
927.8
-2.53%52W Range
Market Cap
₹12,388.72 Cr
Traded: ₹16.93 Cr (0.14%) 0.0x
Free Float: ₹2,335.27 Cr (0.73% of FF traded)
Volume · 60D trend
1.82 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +18.0% | +18.0% | +17.0% | -- | -- | Stable |
| Return | +16.0% | +21.0% | +19.0% | +29.0% | -- | Stable |
| Profit | +12.0% | +16.0% | +11.0% | -- | +37.0% | Stable |
| Sales | +17.0% | +29.0% | +29.0% | -- | +24.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Sep 2026PDF ↗ | Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,211 | 1,200 | 1,224 | 1,051 | 1,127 | 1,056 | 836 | 758 | 738 | 773 | 727 | 664 | 608 | 655 | 520 | 535 | 507 |
| Expenses | 999 | 1,007 | 1,033 | 866 | 930 | 897 | 673 | 634 | 601 | 643 | 609 | 554 | 498 | 549 | 407 | 435 | 409 |
| Operating Profit | 212 | 194 | 192 | 185 | 197 | 159 | 163 | 124 | 137 | 130 | 118 | 111 | 110 | 106 | 113 | 101 | 98 |
| Other Income | 5 | 3 | 2 | 3 | 1 | 2 | 4 | 3 | 1 | 1 | 4 | 1 | 1 | 0 | 2 | 0 | 0 |
| Interest | 26 | 29 | 30 | 32 | 33 | 34 | 34 | 31 | 27 | 21 | 21 | 23 | 18 | 15 | 11 | 11 | 7 |
| Depreciation | 40 | 39 | 40 | 39 | 39 | 34 | 27 | 25 | 24 | 23 | 31 | 22 | 23 | 22 | 10 | 19 | 17 |
| Profit Before Tax | 151 | 129 | 123 | 116 | 127 | 94 | 106 | 72 | 87 | 87 | 70 | 67 | 70 | 69 | 95 | 71 | 73 |
| Tax % | 14.0% | 9.0% | 7.0% | 14.0% | 21.0% | 23.0% | 4.0% | 12.0% | 15.0% | 18.0% | 7.0% | 5.0% | 13.0% | 13.0% | 10.0% | -4.0% | 21.0% |
| Net Profit | 130 | 117 | 115 | 100 | 101 | 72 | 102 | 63 | 74 | 71 | 65 | 63 | 61 | 61 | 85 | 73 | 58 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 9.7 | 8.8 | 8.6 | 7.5 | 7.5 | 5.4 | 7.6 | 4.7 | 5.5 | 5.3 | 4.9 | 4.8 | 4.6 | 4.6 | 6.4 | 5.5 | 4.3 |
| Sales Growth (YoY) | 7.5% | 13.6% | 46.4% | 38.6% | 52.7% | 36.6% | 15.0% | 14.2% | 21.4% | 18.0% | 39.8% | 24.1% | 19.9% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 0.9% | -2.0% | 16.5% | -6.7% | 6.7% | 26.3% | 10.3% | 2.7% | -4.5% | 6.3% | 9.5% | 9.2% | -7.2% | 26.0% | -2.8% | 5.5% | -- |
| OP Growth (YoY) | 7.6% | 22.0% | 17.8% | 49.2% | 43.8% | 22.3% | 38.1% | 11.7% | 24.5% | 22.6% | 4.4% | 9.9% | 12.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | 9.3% | 1.0% | 3.8% | -6.1% | 23.9% | -2.5% | 31.5% | -9.5% | 5.4% | 10.2% | 6.3% | 0.9% | 3.8% | -6.2% | 11.9% | 3.1% | -- |
| Profit Growth (YoY) | 29.0% | 61.0% | 12.0% | 59.0% | 36.0% | 1.0% | 56.0% | 0.0% | 22.0% | 18.0% | -24.0% | -13.0% | 5.0% | 15.0% | 62.0% | 25.0% | 17.0% |
| EPS Growth (YoY) | 29.0% | 61.1% | 12.4% | 59.1% | 36.3% | 1.5% | 56.4% | -0.8% | 21.2% | 17.3% | -23.9% | -13.3% | 5.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 11.3% | 2.0% | 14.3% | -0.5% | 39.0% | -28.8% | 61.6% | -14.8% | 3.5% | 9.6% | 2.5% | 4.2% | 0.2% | -28.9% | 16.8% | 26.5% | -- |
| OP Margin | 17.5% | 16.2% | 15.7% | 17.6% | 17.5% | 15.1% | 19.5% | 16.4% | 18.6% | 16.8% | 16.2% | 16.7% | 18.1% | 16.2% | 21.7% | 18.9% | 19.3% |
| Net Margin | 10.7% | 9.8% | 9.4% | 9.5% | 9.0% | 6.8% | 12.2% | 8.3% | 10.0% | 9.2% | 8.9% | 9.5% | 10.0% | 9.3% | 16.4% | 13.6% | 11.4% |
| Material Cost % | 62.0% | 65.0% | 65.0% | 63.0% | 65.0% | 67.0% | 56.0% | 60.0% | 60.0% | 62.0% | 57.0% | 59.0% | 58.0% | 60.0% | 48.0% | 56.0% | 55.0% |
| Employee Cost % | 4.0% | 4.0% | 5.0% | 5.0% | 4.0% | 4.0% | 6.0% | 6.0% | 5.0% | 5.0% | 6.0% | 5.0% | 5.0% | 5.0% | 8.0% | 5.0% | 5.0% |
| P/S | 2.64 | 3.15 | 3.52 | 3.96 | 3.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 26.83 | 33.51 | 40.40 | 42.95 | 40.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.65 | 6.18 | 6.69 | 7.73 | 6.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50The transcript of the concall held on 16.10.2026 is being attached herewith
In terms of Regulation 30(6) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Audio Recording ....
The Board of Directors in their just concluded meeting accepted the resignation of Ms. Sridevi Dasari from the office of Company Secretary & Compliance officer (KMP) of the Company with ....
The Board of Directors in their just concluded meeting appointed Mr. Kallepally Bharath Kumar to the office of Company Secretary & Compliance Officer (KMP) of the Company effective November ....
The Board of Directors in their concluded meeting has approved the unaudited standalone and consolidated financial results of the company for the second quarter and half year ended September ....
We wish to inform you that the Board of Directors of the Company, at their just concluded meeting, have decided on the following: 1. Approved the Un-audited Standalone Financial Results ....
This is to inform that an investors call has been scheduled for 16th October 2026 at 11.00AM to discuss the unaudited results of the company for the second quarter and half year ended 30th ....
Please find enclosed the certificate as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
CCL Products (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2026 ,inter alia, to consider and approve the unaudited financial ....
This is to inform you regarding the trading window closure for the quarter and half year ended September 30, 2026.
The information towards the exercise of ESOPs pursuant to the CCL Employee Stock Option Scheme, 2022, is being attached herewith.
The Voting Results along with the Signed Scrutiniser''s report is being attached herewith.
The Scrutiniser''s report for the resolution proposed at the AGM are being attached herewith.
The link of the recording of the 65th AGM of the Company is mentioned in the attached document
The Outcome/ Proceedings of the AGM is being attached herewith.
The notice of the 65th AGM for the FY 2025-26 along with the annual report is being attached herewith.
The Business Responsibility and Sustainability Report for the FY 25-26 is attached herewith
The Annual report for the FY 25-26 is being attached herewith.
The Board of Directors in its meeting held on 27.07.2026 has fixed September 01, 2026 as record date for payment of final dividend of Rs.3 per equity share (nominal value Rs.2 each).
The Board of Directors at their just concluded meeting has approved the unaudited (Standalone & Consolidated) financial results for the quarter ended June 30, 2026 as recommended by the ....
The Board of Directors of the Company, at their just concluded meeting, have decided on the following matters: 1. Approved the un-audited standalone & consolidated financial results for ....
This is to inform that the conference call for the results of the first quarter will be held on 28.07.2026 at 10.00 A.M. The joining link is being attached in the annexure of the attachment herewith.
This is to inform that 2000 equity shares have been allotted under the CCL Employee Stock Option Scheme-2022
CCL Products (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve the unaudited financial ....
We wish to inform you that 2100 equity shares on 13.07.2026 pursuant to CCL Employees Stock Option Scheme, 2022.
The certificate of compliances under the regulation is being attached herewith
This is to inform you that the trading window shall remained closed for trading in securities of the company from July 1, 2026 upto 48 hours of conclusion of the board meeting, the date ....
This is to inform you that the Company will be participating in the Investor Conference titled 'CHAIRMAN, MD & CEO Virtual Investor Days'organized by the Ashika Group.
This is to inform you that the Company is participating in an investor conference which shall be held on Monday, June 15, 2026.
This is to inform you that the Company is participating in a conference call to be held on Tuesday, June 16, 2026. The details are being attached herewith for your kind perusal.
The Exchange has sought clarification from CCL Products (India) Ltd on June 9, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
We hereby submit our clarification relating to the volume movement in reply to your mail dated 09.06.2026
An Investor conference (through Video Conference mode) is organized by Ashika Institutional Equities, scheduled to be held on Wednesday, May 27, 2026, where the Company will be interacting ....
The transcript of the Q4 conference call held on 08.05.2026 is being attached herewith.
The audio recording link for the Q4 conference call held on 08.05.2026 is being attached herewith.
The Nomination Remuneration Committee of the Company, in its meeting held on 07.05.2026, granted and vested options along with the approving changes in the structure of Senior Management ....
The Board of directors of the company has approved final dividend of Rs. 3/- per share on the face value of Rs. 2 per equity share at its meeting held on 07.05.2026
The financial results for the financial year ended march 31, 2026 is being attached herewith
The Outcome of the board meeting is being attached hereiwth
In continuation to our previous announcement, the link for joining the conference call is revised and is being shared herewith.
A conference call to discuss the audited financial results shall be held on 08th May, 2026. The dial-in numbers are annexed to the intimation herewith.
CCL Products (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and approve the financial results ....
We would like to inform that India Ratings & Research has revised the Outlook on CCL Products (India) Limited and its bank facilities to Stable from Negative while affirming the rating ....
Please find enclosed the certificate as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This is for your information and necessary records.
We wish to inform you that the Trading window for transactions in shares of the Company for all the designated persons and their immediate relatives will remain closed from April 01, 2026 ....
Mr. Thirumala Prasad Rajanandam, Deputy General Manager - Commercial of the Company, who is a Senior Managerial Personnel of the Company as per Regulation 16(1)(d) of the SEBI (LODR) Regulations, ....
Allotment of 319 equity shared of Rs. 2/- pursuant to CCL Employee Stock Option Scheme, 2022
Allotment of 319 equity shares of Rs.2 /- under the CCL Employee Stock Option Scheme, 2022
The clarification letter is attached herewith
The Exchange has sought clarification from CCL Products (India) Ltd on February 24, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
Annual Reports
15Credit Ratings
6Concalls
37Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Jul 2023
31 Jul 2023Jul 2023
31 Jul 2023Jul 2023
31 Jul 2023Jul 2023
31 Jul 2023May 2023
31 May 2023Jan 2023
31 Jan 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jun 2022
30 Jun 2022Jan 2022
31 Jan 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021May 2021
31 May 2021Feb 2021
28 Feb 2021Oct 2020
31 Oct 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Nov 2019
30 Nov 2019Jul 2019
31 Jul 2019May 2019
31 May 2019Mar 2019
31 Mar 2019Oct 2018
31 Oct 2018Oct 2018
31 Oct 2018Jul 2018
31 Jul 2018Held by ETFs
12 ETFs hold CCL · sorted by weight
Held by Mutual Funds
49 schemes hold CCL · sorted by weight